Mutations in the flavin-containing monooxygenase form 3 (FMO3) gene cause trimethylaminuria, fish odour syndrome.

被引：0
|
作者：
Akerman, BR
Chow, L
Forrest, S
Youil, R
Cashman, J
Treacy, EP
机构：
[1] McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3H 1P3, Canada
[2] Royal Childrens Hosp, Murdoch Inst, Melbourne, Vic, Australia
[3] Seattle Biomed Res Inst, Seattle, WA 98109 USA
[4] Merck Res Labs, W Point, PA USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 61卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
281
引用
收藏
页码：A53 / A53
页数：1
相关论文
共 50 条
  • [21] POSTNATAL EXPRESSION AND TISSUE DISTRIBUTION OF FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3)
    Xu, Zhen
    Yan, Bingfang
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S83 - S83
  • [22] Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
    El-Serafi, Ibrahim
    Terelius, Ylva
    Abedi-Valugerdi, Manuchehr
    Naughton, Sean
    Saghafian, Maryam
    Moshfegh, Ali
    Mattsson, Jonas
    Potacova, Zuzana
    Hassan, Moustapha
    PLOS ONE, 2017, 12 (11):
  • [23] Trimethylamine biosensor with flavin-containing monooxygenase type 3 (FMO3) for fish-freshness analysis
    Mitsubayashi, K
    Kubotera, Y
    Yano, K
    Hashimoto, Y
    Kon, T
    Nakakura, S
    Nishi, Y
    Endo, H
    SENSORS AND ACTUATORS B-CHEMICAL, 2004, 103 (1-2): : 463 - 467
  • [24] A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome:: activity of the mutant enzyme assessed by proton NMR spectroscopy
    Murphy, HC
    Dolphin, CT
    Janmohamed, A
    Holmes, HC
    Michelakakis, H
    Shephard, EA
    Chalmers, RA
    Phillips, IR
    Iles, RA
    PHARMACOGENETICS, 2000, 10 (05): : 439 - 451
  • [25] A family study of compound variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects found by urinary phenotyping for trimethylaminuria
    Shimizu, Makiko
    Yamamoto, Akane
    Makiguchi, Miaki
    Shimamura, Erika
    Yokota, Yuka
    Harano, Mizuki
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 50
  • [26] OXYGENATION ACTIVITIES OF THE FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3) VARIANTS FOUND IN JAPANESE
    Nagashima, Satomi
    Shimizu, Makiko
    Yano, Hiroshi
    Murayama, Norie
    Yamazaki, Hiroshi
    DRUG METABOLISM REVIEWS, 2007, 39 : 260 - 260
  • [27] ANALYSIS OF SUPPRESSION AND ACTIVATION OF THE HAPLOTYPED FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3) GENE TRANSCRIPTIONS IN JAPANESE
    Shimizu, Makiko
    Murayama, Norie
    Nagashima, Satomi
    Fujieda, Masaki
    Yamazaki, Hiroshi
    DRUG METABOLISM REVIEWS, 2008, 40 : 148 - 148
  • [28] Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources
    Shimizu, Makiko
    Koibuchi, Natsumi
    Mizugaki, Ami
    Hishinuma, Eiji
    Saito, Sakae
    Hiratsuka, Masahiro
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2021, 38
  • [29] Flavin-containing Monooxygenase (FMO3) Links the Gut and Fibrosis in Systemic Sclerosis
    Verma, Priyanka
    Yalavarthi, Bharath
    Ho, Karen
    Muhammad, Lutfiyya
    Kim, Seokjo
    Gudjonsson, Johann
    Schugar, Rebecca C.
    Brown, Mark
    Li, Xinmin
    Hazen, Stanley L.
    Bhattacharyya, Swati
    Varga, John
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1874 - 1876
  • [30] In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles
    Cashman, JR
    Xiong, Y
    Lin, J
    Verhagen, H
    van Poppel, G
    van Bladeren, PJ
    Larsen-Su, S
    Williams, DE
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (06) : 1047 - 1055
12345